Abbott pays $1.6 billion to settle Depakote claims

Abbott will pay $1.6 billion to settle US legal claims over its epilepsy drug Depakote.  The $1.6 billion will settle claims by the US government that allege the firm illegally marketed Depakote…
Read the full story: InPharm